Skip to content
DataLookout
Menu

NCT07806838

Effects of Dietary Supplements on Muscle Mass and Function While Using GLP-1 Medication

StatusRecruiting
PhaseNot applicable
Primary completion (estimated)
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 2 versions: 2 with changes below.

  1. Minor Start date changed from estimate of Sep 10, 2026 to Oct 22, 2026
  2. Study First Submitted
  • Minor: routine updates

Endpoints

Primary

Change in Muscle Mass Measured by DEXA
Timeframe: Baseline, 3 months, and 6 months
Change in Muscle Mass Measured by D3-Creatine Enrichment
Timeframe: Baseline and 6 months

Secondary (18)

Change in 400-Meter Walk Test Performance
Change in Stair Climbing Test Performance
Change in Grip Strength
Change in Mitochondrial Function
Change in Fasting Glucose
Show 13 moreShow less
Change in Fasting Insulin
Change in C-Peptide
Change in Glucagon
Change in Glucose-Dependent Insulinotropic Polypeptide (GIP)
Change in High-Sensitivity C-Reactive Protein (hs-CRP)
Change in Body Weight
Change in Body Composition by Bioelectrical Impedance Analysis
Change in Fatigue Assessed by PROMIS Fatigue Short Form 8a
Change in Quality of Life Assessed by SF-36
Change in Sleep Quality Assessed by Pittsburgh Sleep Quality Index (PSQI)
Change in Dietary Energy and Macronutrient Intake
Change in Physical Activity
Change in Gut Microbiome Composition

Arms and interventions

Arm 1 - Standard of CareNo intervention

Participants will continue their prescribed GLP-1 medication and routine clinical management under the direction of their treating healthcare provider. The study will not determine GLP-1 medication selection, dosing, dose adjustments, or clinical management. Participants will receive standardized dietary/calorie and physical activity guidance and will complete the same study assessments and follow-up visits as participants in the intervention groups. They will not receive the study protein supplement, spice capsules, or placebo capsules.

Protein Supplementation + PlaceboPlacebo comparator

Participants will receive protein supplementation with a goal of total protein intake of 1.2 g/kg lean body mass per day, based on baseline lean body mass measured by DEXA, plus placebo capsules containing 4 g of maltodextrin daily for 6 months. Participants will also receive standardized dietary/calorie and physical activity guidance.

Protein Supplementation + Mixed SpicesExperimental

Participants will receive protein supplementation with a goal of total protein intake of 1.2 g/kg lean body mass per day, based on baseline lean body mass measured by DEXA, plus 4 g of mixed spice capsules daily for 6 months. The daily spice mixture contains 1.0 g turmeric, 1.5 g cinnamon, 0.5 g oregano, 0.5 g black pepper, 0.3 g sage, and 0.2 g thyme. Participants will also receive standardized dietary/calorie and physical activity guidance.

Dietary supplements: Whey Protein Supplementation, Maltodextrin Placebo Capsules, Mixed Spice Capsules

Sites

1 site in 1 country

  • UCLA Center for Human NutritionLos Angeles, California, United States